MAP2K7 and neoplasm: A PK study was carried out with samples taken 6 and 24 h after treatment with a single dose of the PI3K inhibitor WX-037 and the MEK inhibitor WX-554, alone and in combination, in HCT116 and HT29 human tumour xenograft-bearing mice.